IRIS - Res&Arch Institutional Research Information System - Research & Archive

LUCIDI, Paola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.133
EU - Europa 2.290
AS - Asia 2.179
SA - Sud America 314
AF - Africa 53
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.989
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.061
SG - Singapore 1.081
IE - Irlanda 340
CN - Cina 315
IT - Italia 313
UA - Ucraina 310
RU - Federazione Russa 309
BR - Brasile 237
HK - Hong Kong 234
SE - Svezia 219
FR - Francia 198
DE - Germania 182
VN - Vietnam 173
FI - Finlandia 134
GB - Regno Unito 106
BD - Bangladesh 75
IN - India 65
KR - Corea 47
TR - Turchia 46
CA - Canada 34
AT - Austria 31
PL - Polonia 29
AR - Argentina 28
ES - Italia 26
MX - Messico 24
ZA - Sudafrica 22
IQ - Iraq 19
JP - Giappone 19
AU - Australia 16
NL - Olanda 16
UZ - Uzbekistan 14
BE - Belgio 12
ID - Indonesia 12
CH - Svizzera 11
SA - Arabia Saudita 11
CO - Colombia 10
EC - Ecuador 10
PH - Filippine 10
PK - Pakistan 10
VE - Venezuela 10
CZ - Repubblica Ceca 9
RO - Romania 8
LB - Libano 7
GR - Grecia 6
KE - Kenya 6
MA - Marocco 6
NP - Nepal 6
PE - Perù 6
BO - Bolivia 5
DK - Danimarca 5
RS - Serbia 5
AL - Albania 4
AZ - Azerbaigian 4
DZ - Algeria 4
EG - Egitto 4
JM - Giamaica 4
JO - Giordania 4
MY - Malesia 4
OM - Oman 4
CL - Cile 3
EE - Estonia 3
IL - Israele 3
KZ - Kazakistan 3
LT - Lituania 3
PS - Palestinian Territory 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BW - Botswana 2
BY - Bielorussia 2
EU - Europa 2
GE - Georgia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PY - Paraguay 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GF - Guiana Francese 1
HR - Croazia 1
HT - Haiti 1
KG - Kirghizistan 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
MT - Malta 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
SI - Slovenia 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 7.988
Salva come PNG Salva come JPEG
Città #
Singapore 778
Chandler 383
Dublin 340
San Jose 329
Hong Kong 231
Ashburn 208
San Mateo 198
Jacksonville 179
Boardman 143
Santa Clara 113
Altamura 112
Moscow 100
Medford 97
Princeton 96
Wilmington 90
Lauterbourg 85
Perugia 80
Beijing 78
Ann Arbor 74
Lawrence 74
New York 72
Munich 65
Los Angeles 59
Dong Ket 57
Seoul 46
Helsinki 44
Andover 39
Ho Chi Minh City 39
Des Moines 28
Brooklyn 26
Saint Petersburg 26
Rome 25
São Paulo 21
The Dalles 21
Woodbridge 21
Piscataway 20
Chicago 19
Izmir 19
Warsaw 19
Frankfurt am Main 18
Hanoi 18
Norwalk 18
Vienna 18
Amelia 17
Fremont 17
Tokyo 17
Turku 16
Nuremberg 15
Orem 15
Valencia 14
Denver 13
Stockholm 13
Montreal 12
Brussels 11
Amsterdam 10
Ankara 10
Falkenstein 10
Falls Church 10
San Paolo di Civitate 10
Tashkent 10
Houston 9
Poplar 9
Atlanta 8
Belo Horizonte 8
Chennai 8
Dallas 8
London 8
Manchester 8
Milan 8
Redwood City 8
Shanghai 8
Bexley 7
Haiphong 7
Istanbul 7
Johannesburg 7
Redmond 7
San Diego 7
Toronto 7
Baghdad 6
Cardiff 6
Da Nang 6
Hyderabad 6
Juárez 6
Melbourne 6
Renton 6
Athens 5
Belgrade 5
Bolton 5
Brno 5
Bucu 5
Buenos Aires 5
Lausanne 5
Mumbai 5
Porto Alegre 5
Riyadh 5
San Francisco 5
Simi Valley 5
Amman 4
Auburn Hills 4
Baku 4
Totale 4.999
Salva come PNG Salva come JPEG
Nome #
Hypoglycemia 151
18. Insulin required for prandial ghrelin suppression in humans 136
Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia. 134
Alternative indicators of metabolic control 128
Portal vein glucose sensors do not play a major role in modulating physiological responses to insulin-induced hypoglycemia in humans. 126
A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults 126
Liver protein synthesis in physiology and in disease states 125
A novel surrogate index for hepatic insulin resistance. 124
Circulating palmitoleic acid is an independent determinant of insulin sensitivity, beta cell function and glucose tolerance in non-diabetic individuals: a longitudinal analysis 123
Pharmacokinetics and pharmacodynamic of therapeutic dose of basel insulins NPH, Glargine and Detemir after one week of daily administration at bedtime in Type 2 daibates: a randomized, cross-over study. 119
Comparison of pharmacokinetics and-dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes mellitus: a double-blind, randomized, cross-over study. 118
A randomized controlled trial to evaluate the efficacy of ultrasound-guided laser photocoagulation for treatment of benign thyroid nodules. 118
Physiological increments in plasma insulin concentrations have selective and different effects on synthesis of hepatic proteins in normal humans. 116
Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes mellitus. 116
Administration of Recombinant Human GH on Alternate Days is sufficient to increase whole Body Protein Synthesis and Lipolysis in GH Deficient Adults 114
Ipoglicemia: implicazioni cliniche e impatto sulla salute 112
Contribution of amino acids and insulin to protein anabolism during meal absorption. 111
Short-term effects of the long-acting insulin analog detemir and human insulin on plasma levels of insulin-like growth factor-I and its binding proteins in humans. 111
Effects of dietary protein restriction on fibrinogen and albumin metabolism in nephrotic patients 107
Influence of the ACE gene insertion/deletion polymorphism on insulin sensitivity and impaired glucose tolerance in healthy subjects. 107
Body weight, not insulin sensitivity or secretion, may predict spontaneous weight changes in nondiabetic and prediabetic subjects: the RISC study. 107
Pharmacokinetics and pharmacodynamics of insulin glargine given in the evening as compared with in the morning in type 2 diabetes 107
Insulin is required for prandial ghrelin suppression in humans 107
Advances in Hepatic Encephalopathy and Metabolic Nitrogen Exchange 105
A randomized controlled trial to evaluate the efficacy of ultrasound-guided laser photocoagulation for treatment of benign thyroid nodules 101
Fasting insulin has a stronger association with an adverse cardiometabolic risk profile than insulin resistance: the RISC study. 100
Influence of Apolipoproteins on the Association Between Lipids and Insulin Sensitivity: A cross-sectional analysis of the RISC Study 99
Pivotal role of timely basal insulin replacement after metformin failure in sustaining long-term blood glucose control at a target in Type 2 diabetes. 96
Ethanol impairs post-prandial hepatic protein metabolism 95
Body composition and common carotid artery remodeling in a healthy population 94
Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis. 93
PHARMACOKINETIC AND PHARMACODYNAMIC HEAD-TO-HEAD COMPARISON OF CLINICAL, EQUIVALENT DOSES OF INSULIN GLARGINE 300 U/ML AND INSULIN DEGLUDEC 100 U/ML IN TYPE 1 DIABETES 93
Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population. 93
SHORT-TERM TREATMENT WITH LOW DOSES OF RECOMBINANT HUMAN GROWTH HORMONE (GH) STIMULATES LIPOLYSIS IN VISCERAL OBESE MEN 92
Pharmacokinetics, pharmacodynamics, and modulation of hepatic glucose production with insulin glargine U300 and glargine U100 at steady state with individualized clinical doses in type 1 diabetes 92
Greater Suppression of Glucagon, Lipolysis, and Ketogenesis with Insulin Glargine U300 as Compared with Glargine U100 in Type 1 Diabetes Mellitus 92
Termoablazione laser percutanea quale alternativa all’intervento di tiroidectomia totale nei pazienti ad alto rischio operatorio 91
Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial 89
Effects of dietary protein restriction on albumin and fibrinogen synthesis in macroalbuminuric type 2 diabetic patients. 89
Metabolism of insulin glargine after repeated daily subcutaneous injections in subjects with type 2 diabetes. 89
Chloroquine reduces whole body proteolysis in humans 88
Ricoveri per ipoglicemia grave in soggetti con diabete mellito di tipo 2: impatto clinico e costi sanitari 86
HYPERGLYCEMIA-INDUCED PLATELET ACTIVATION IN TYPE 2 DIABETES MELLITUS IS RESISTANT TO ASPIRIN BUT NOT TO A NITRIC OXIDE-DONATING AGENT. 85
Make your diabetic patients walk: long-term impact of different amounts of physical activity on type 2 diabetes. 83
L’ipoglicemia silente nella pratica clinica quotidiana: come diagnosticarla, gestirla e prevenirla 83
Dietary protein intake does not affect IgG synthesis in patients with nephrotic syndrome. 82
Insulin sensitivity and carotid intima-media thickness: relationship between insulin sensitivity and cardiovascular risk study. 82
Glargine metabolism over 24 h following its subcutaneous injection in patients with type 2 diabetes mellitus: A dose–response study 82
Physical inactivity is the main cause of the metabolic syndrome 81
Circulatin ghrelin levels of visceral obese men are not modified by a short-term treatment with very low doses of GH replacement 81
Pharmacokinetics and pharmacodynamics of NPH insulin in type 1 diabetes: The Importance of appropriate resuspension before subcutaneous injection 81
Increased albumin and fibrinogen synthesis in hemodialysis patients with normal nutritional status 80
Thirty years of research on the dawn phenomenon: lessons to optimize blood glucose control in diabetes. 80
Obesity and carotid artery remodeling 79
One hour post-load plasma glucose and 3 year risk of worsening fasting and 2 hour glucose tolerance in the RISC cohort 79
Female Sex and Angiotensin-Converting Enzyme (ACE) Insertion/Deletion Polymorphism Amplify the Effects of Adiposity on Blood Pressure 78
Circulating ghrelin concentrations in the polycystic ovary syndrome 75
Low levels of unmodified insulin glargine in plasma of people with type 2 diabetes requiring high doses of basal insulin 73
Effect of sedentary behaviour and vigorous physical activity on segment-specific carotid wall thickness and its progression in a healthy population 72
Circulating ghrelin levels of visceral obese men are not modified by a short-term treatment with very low doses of GH replacement. 72
Diurnal Cycling of Insulin Sensitivity in Type 2 Diabetes: Evidence for Deviation From Physiology at an Early Stage 71
Effects of dietary protein restriction on fibrinogen and albumin metabolism in nephrotic patients 69
Liver enzymes are associated with hepatic insulin resistance, insulin secretion, and glucagon concentration in healthy men and women. 69
The effect of menopause on carotid artery remodeling, insulin sensitivity, and plasma adiponectin in healthy women 69
Moderate and large doses of ethanol differentially affect hepatic protein metabolism in humans 68
Gamma-glutamyltransferase, arterial remodeling and prehypertension in a healthy population at low cardiometabolic risk 68
Optimizing the replacement of basal insulin in Type 1 diabetes mellitus: no longer an elusive goal in the post-NPH era. 66
Different insulin concentrations in resuspended vs. unsuspended NPH insulin: Practical aspects of subcutaneous injection in patients with diabetes. 66
Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study. 64
INSULIN SENSITIVITY IN TYPE 2 DIABETIC PATIENTS IS DIFFERENT BETWEEN GLUCOSE AND PROTEIN METABOLISM 63
How to accurately establish pharmacokinetics/ pharmacodynamics of long- Acting insulins in humans: Relevance to biosimilar insulins 63
Prevention and Management of Severe Hypoglycemia and Hypoglycemia Unawareness: Incorporating Sensor Technology 63
Metabolic and endocrine effects of physiological increments in plasma ghrelin concentrations 62
Tecniche Nefrologiche e dialitiche 62
Impact of family history on relations between insulin resistance, LDL cholesterol and carotid IMT in healthy adults 61
The physiological basis of insulin therapy in people with diabetes mellitus 60
Effects of whole-body vibration exercise on the endocrine system of healthy men. 59
Treatment of growth hormone deficiency syndrome in adults 58
Nicotinamide counteracts alcohol-induced impairment of hepatic protein metabolism in humans 58
Gender differences in basal protein kinetics in young adults 58
The role of gastric emptying in glucose homeostasis and defense against hypoglycemia: Innocent bystander or partner in crime? 57
Ghrelin is not necessary for adequate hormonal counterregulation of insulin-induced hypoglycemia 57
Real-time continuous glucose monitoring decreases the risk of severe hypoglycemia in people with type 1 diabetes and impaired awareness of hypoglycemia 57
Impact of patient and treatment characteristics on glycemic control and hypoglycemia in patients with type 2 diabetes initiated to insulin glargine or NPH: A post hoc, pooled, patient-level analysis of 6 randomized controlled trials 57
Validation of a counseling strategy to promote the adoption and the maintenance of physical activity by Type 2 diabetic subjects. 56
Reductions in A1C with pump therapy in type 2 diabetes are independent of C-peptide and anti-glutamic acid decarboxylase antibody concentrations 55
Metabolic effects of an SGLT2 inhibitor (Dapagliflozin) during a period of acute insulin withdrawal and development of ketoacidosis in people with type 1 diabetes. Diabetes care 2020;43:2128– 2136 55
Plasma ghrelin concentrations, food intake, and anorexia in liver failure 54
Insulin sensitivity and beta-cell function in the offspring of type 2 diabetic patients: impact of line of inheritance. 53
From Metabolic Normality to Cardiometabolic Risk Factors in Subjects With Obesity 53
Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population 51
Meal intake similarly reduces circulating concentrations of octanoyl and total ghrelin in humans 51
Ethanol impairs post-prandial hepatic protein metabolism. 49
Fatty liver index, gamma-glutamyltransferase, and early carotid plaques. 48
Plasma Insulin Levels and Hypoglycemia Affect Subcutaneous Interstitial Glucose Concentration 48
GLP-1 RAs as compared to prandial insulin after failure of basal insulin in type 2 diabetes: Lessons from the 4B and Get-Goal DUO 2 trials 47
One-hundred year evolution of prandial insulin preparations: From animal pancreas extracts to rapid-acting analogs 46
Glucose Control in Diabetes: Targets and Therapy 42
The Modern Role of Basal Insulin in Advancing Therapy in People With Type 2 Diabetes 9
An overview of randomized clinical trials of fixed‐ratio combinations of basal insulin plus GLP ‐ 1RA (injectable therapy): Lessons for advancing therapy in people with type 2 diabetes 8
Totale 8.178
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.132
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.132
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202172 0 0 0 0 0 0 0 0 0 0 0 72
2021/2022706 12 137 21 38 18 9 8 231 7 18 99 108
2022/20231.259 99 264 17 89 92 158 0 58 445 1 28 8
2023/2024519 35 49 28 7 2 11 100 0 54 26 103 104
2024/20251.320 10 124 31 79 203 43 38 108 292 93 169 130
2025/20262.912 219 184 157 271 413 214 546 138 378 204 115 73
Totale 8.178